International Journal of Tuberculosis and Lung Disease

(The median citation count of International Journal of Tuberculosis and Lung Disease is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 500 papers]. The publications cover those that have been published in the past four years, i.e., from 2019-10-01 to 2023-10-01.)
The impact of COVID-19 on TB: a review of the data121
The GOLD Summit on chronic obstructive pulmonary disease in low- and middle-income countries79
Post-tuberculosis lung health: perspectives from the First International Symposium76
Effect of chronic obstructive pulmonary disease and smoking on the outcome of COVID-1967
Clinical standards for the assessment, management and rehabilitation of post-TB lung disease45
The impact of alcohol use on tuberculosis treatment outcomes: a systematic review and meta-analysis45
New diseases and old threats: lessons from tuberculosis for the COVID-19 response37
COVID-19 and tuberculosis—threats and opportunities36
Impact of COVID-19 on tuberculosis control in China32
Impact of COVID-19 on TB diagnosis in Northeastern Brazil32
Impact of the COVID-19 pandemic on the detection of TB in Shanghai, China29
Impact of COVID-19 on TB care: experiences of a treatment centre in Nigeria29
Mask wearing to complement social distancing and save lives during COVID-1928
Air pollution interventions and respiratory health: a systematic review26
Reduction of diagnostic and treatment delays reduces rifampicin-resistant tuberculosis mortality in Rwanda24
The impact of smoking on tuberculosis treatment outcomes: a meta-analysis23
Clinical and economic impact of medication non-adherence in drug-susceptible tuberculosis: a systematic review23
Tuberculosis contact investigation and short-course preventive therapy among young children in Africa22
A partially randomised trial of pretomanid, moxifloxacin and pyrazinamide for pulmonary TB22
Post-tuberculosis sequelae: the need to look beyond treatment outcome22
Tobacco control in China and the road to Healthy China 203021
Should we consider a ‘fourth 90’ for tuberculosis?20
Functional impact of sequelae in drug-susceptible and multidrug-resistant tuberculosis20
A decrease in tuberculosis evaluations and diagnoses during the COVID-19 pandemic19
Clinical standards for the diagnosis, treatment and prevention of TB infection19
Severe COVID-19 cases with a history of active or latent tuberculosis19
Diagnosing pulmonary aspergillosis is much easier than it used to be: a new diagnostic landscape19
The need for pulmonary rehabilitation following tuberculosis treatment18
Impact of the global COVID-19 outbreak on the management of other communicable diseases18
The Global Asthma Report 202218
How TB and COVID-19 compare: an opportunity to integrate both control programmes18
Impact of COVID-19 on tuberculosis services in India18
Occupational asthma18
Interventions to reduce losses in the cascade of care for latent tuberculosis: a systematic review and meta-analysis18
Critical changes to services for TB patients during the COVID-19 pandemic17
TB and COVID-19 co-infection: rationale and aims of a global study17
The COVID-19 and TB syndemic: the way forward17
Adapting TB services during the COVID-19 pandemic in Mumbai, India17
Acceptability of a first-line anti-tuberculosis formulation for children: qualitative data from the SHINE trial17
Thrombotic events and COVID-19 vaccines17
Treatment outcomes in patients with drug-resistant TB-HIV co-infection treated with bedaquiline and linezolid16
Household air pollution and COPD: cause and effect or confounding by other aspects of poverty?16
Asbestos-related diseases15
Persistent chronic respiratory symptoms despite TB cure is poorly correlated with lung function15
Resource reprioritisation amid competing health risks for TB and COVID-1915
Linezolid for the treatment of extensively drug-resistant tuberculosis: a systematic review and meta-analysis14
Impact of shelter-in-place on TB case notifications and mortality during the COVID-19 pandemic13
Pulmonary TB and chronic pulmonary aspergillosis: clinical differences and similarities13
Comparative analysis of Truenat™ MTB Plus and Xpert® Ultra in diagnosing tuberculous meningitis13
TB and the COVID-19 pandemic: brothers in arms against lung health13
Mortality due to TB-COVID-19 coinfection in India13
Clinical standards for the dosing and management of TB drugs13
Availability of diagnostic services and essential medicines for non‐communicable respiratory diseases in African countries13
Computer-aided detection for tuberculosis and silicosis in chest radiographs of gold miners of South Africa13
Diabetes and body mass index in relation to risk of active tuberculosis: a prospective population-based cohort12
A global update on rare non-tuberculous mycobacteria in humans: epidemiology and emergence12
How to demystify COVID-19 and reduce social stigma12
Multidrug-resistant tuberculosis in the Kharkiv Region, Ukraine12
National population-based tuberculosis prevalence survey in Ghana, 201312
Evaluation of recorded video-observed therapy for anti-tuberculosis treatment12
Implementing novel regimens for drug-resistant TB in South Africa: what can the world learn?12
The burden and determinants of post-TB lung disease12
Tuberculosis from transmission in clinics in high HIV settings may be far higher than contact data suggest12
WHO drug-resistant TB guidelines 2022: what is new?11
Automated chest radiography and mass systematic screening for tuberculosis11
Let us not forget the mask in our attempts to stall the spread of COVID-1911
Tackling the threat of COVID-19 in Africa: an urgent need for practical planning11
Non-hospitalised COVID-19 patients have more frequent long COVID-19 symptoms11
Person-centred care in TB11
Bedaquiline for multidrug-resistant TB in paediatric patients11
Delays and barriers to early treatment initiation for childhood tuberculosis in India11
TB multimorbidity: a global health challenge demanding urgent attention11
Mycobacterium bovis in humans and M. tuberculosis in animals in Nigeria: an overview from 1975–201410
Sustaining essential healthcare in Africa during the COVID-19 pandemic10
Bedaquiline and delamanid result in low rates of unfavourable outcomes among TB patients in Eswatini10
The impact of COVID-19 on the diagnosis of TB in Taiwan10
Ototoxicity among multidrug-resistant TB patients: a systematic review and meta-analysis10
Managing multidrug-resistant tuberculosis in South Africa: a budget impact analysis10
Policies, practices and barriers to implementing tuberculosis preventive treatment—35 countries, 201710
Anthropogenic climate change and health in the Global South9
Risk of hearing loss among multidrug-resistant tuberculosis patients according to cumulative aminoglycoside dose9
Predictive models for COVID-19-related deaths and infections9
Management of rifampicin‐resistant TB: programme indicators and care cascade analysis in South Africa9
A systematic review and meta-analysis of first-line tuberculosis drug concentrations and treatment outcomes9
Serology-positive but minimally symptomatic COVID-19 may still cause lung injury and lung function impairment9
How to manage children if a second wave of COVID-19 occurs9
Evaluation of MTBDRsl for detecting resistance in Mycobacterium tuberculosis to second-line drugs9
The fourth national anti-tuberculosis drug resistance survey in Peru9
Risk factors for chronic pulmonary aspergillosis in post-TB patients9
Identifying latent tuberculosis in high-risk populations: systematic review and meta-analysis of test accuracy9
Patient-cost survey for tuberculosis in the context of patient-pathway modelling9
Evidence for pulmonary rehabilitation in chronic respiratory diseases in sub-Saharan Africa: a systematic review9
Cost of tuberculosis treatment in low- and middle-income countries: systematic review and meta-regression9
Evaluating the use of educational videos to support the tuberculosis care cascade in remote Madagascar9
Geographic distribution, socio-economic disparity and policy determinants of smoke-free policy adoption in Indonesia9
COPD exacerbation rates are higher in non-smoker patients in India8
Pretomanid with bedaquiline and linezolid for drug-resistant TB: a comparison of prospective cohorts8
New TB drugs for the treatment of children and adolescents with rifampicin-resistant TB in Mumbai, India8
First molecular-based anti-TB drug resistance survey in Eritrea8
Real-world implementation of video-observed therapy in an urban TB program in the United States8
Multidisciplinary advisory teams to manage multidrug-resistant tuberculosis: the example of the French Consilium8
Effect of tablet crushing on drug exposure in the treatment of multidrug-resistant tuberculosis8
Preparing national tuberculosis control programmes for COVID-198
Mobile community-based active case-finding for tuberculosis among older populations in rural Cambodia8
Performance of a household tuberculosis exposure survey among children in a Latin American setting8
Priorities among HIV-positive individuals for tuberculosis preventive therapies8
The impact of PM2.5 on lung function in adults with asthma8
Determining the value of TB active case-finding: current evidence and methodological considerations8
First-line tuberculosis treatment with double-dose rifampicin is well tolerated8
Treatment outcomes and predictive factors for multidrug-resistant TB and HIV coinfection in Rio de Janeiro State, Brazil8
Two parallel pandemics: the challenges faced by countries with COVID-19 and TB8
Genomic diversity and transmission dynamics of M. tuberculosis in Africa: a systematic review and meta-analysis8
A comparison of digital chest radiography and Xpert® MTB/RIF in active case finding for tuberculosis8
Breastfeeding in women living with tuberculosis8
Smoking and HIV associated with subclinical tuberculosis: analysis of a population-based prevalence survey8
Latent tuberculosis infection and the EndTB Strategy: ethical tensions and imperatives8
Post-TB health and wellbeing8
Gaps in TB preventive therapy for persons initiating antiretroviral therapy in Uganda: an explanatory sequential cascade analysis7
Monocyte-to-lymphocyte ratio as a predictor of TB among people living with HIV7
Linezolid use for drug-resistant tuberculosis in Georgia: a retrospective cohort study7
Multidrug-resistant tuberculosis in the United States, 2011–2016: patient characteristics and risk factors7
Four of five tuberculosis patients experience catastrophic costs related to TB diagnosis and care in Timor-Leste7
Geographic distribution of chronic obstructive pulmonary disease prevalence in Africa, Asia and Australasia7
Cost of TB services in healthcare facilities in Kenya (No 3)7
Tuberculosis patients with higher levels of poverty face equal or greater costs of illness7
Modelling the potential impact of adherence technologies on tuberculosis in India7
The largest prison outbreak of TB in Western Europe investigated using whole-genome sequencing7
Number needed to screen for TB in clinical, structural or occupational risk groups7
The catastrophic cost of tuberculosis: advancing research and solutions7
Chronic obstructive pulmonary disease in sub-Saharan Africa7
Monitoring the COVID-19 pandemic in sub-Saharan Africa: focusing on health facility admissions and deaths7
Spatial variability in the risk of death from COVID-19 in Italy7
Determinants of lung health across the life course in sub-Saharan Africa7
Minimal clinically important difference of the 6-min walking test in patients with asthma7
Evaluation of a lateral-flow nanoparticle fluorescence assay for TB infection diagnosis7
What is the best culture conversion prognostic marker for patients treated for multidrug-resistant tuberculosis?7
Opportunities to improve digital adherence technologies and TB care using human-centered design6
Impact of COVID-19 on patients with asthma6
TB and TB-HIV care for adolescents and young adults6
The scientific response to TB – the other deadly global health emergency6
Challenges in conducting trials for pediatric tuberculous meningitis: lessons from the field6
An Inca trail to the Holy Grail: digital medication adherence support for TB care6
Costs of TB services in India (No 1)6
High yields from contact investigation of child index TB patients6
Cost savings associated with video directly observed therapy for treatment of tuberculosis6
Unhealthy alcohol use independently associated with unfavorable TB treatment outcomes among Indian men6
Detection of Mycobacterium tuberculosis cell-free DNA to diagnose TB in pediatric and adult patients6
Estimation of subnational tuberculosis burden: generation and application of a new tool in Indonesia6
Respiratory health among office workers in Malaysia and endotoxin and (1,3)-β-glucan in office dust6
A novel approach for eliciting adolescent MDR-TB treatment tolerability: qualitative data from South Africa6
Air conditioners, airborne infection prevention and air pollution in buildings in New Delhi6
Vitamin D status and latent tuberculosis infection: conversion in nursing homes, Spain6
Vitamin D deficiency is associated with tuberculosis disease in British children6
Diurnal variability of fine-particulate pollution concentrations: data from 14 low- and middle-income countries6
Chronic respiratory disease in adult outpatients in three African countries: a cross-sectional study5
Sedimentation rate and suPAR in relation to disease activity and mortality in patients with tuberculosis5
Improving access to affordable quality-assured inhaled medicines in low- and middle-income countries5
Characteristics of a “rebound” in smoking after a tobacco price increase5
Fluoroquinolone preventive therapy for children exposed to MDR-TB5
The effect of systematic screening of the general population on TB case notification rates5
Tuberculosis trends in a hot-spot region in Paris, France5
Costs of multidrug-resistant TB treatment in Finland and Estonia affected by the 2019 WHO guidelines5
Xpert® MTB/RIF Ultra performance in diagnosing paediatric pulmonary TB in gastric aspirates5
Acceptability of levofloxacin, moxifloxacin and linezolid among children and adolescents treated for TB5
Towards quality adolescent-friendly services in TB care5
Rapid development of a portable negative pressure procedural tent5
Clinical perspectives on treatment of rifampicin-resistant/multidrug-resistant TB5
Health-related quality of life associates with clinical parameters in patients with NTM pulmonary disease5
A systematic review of the number needed to screen for active TB among people living with HIV5
Setting up pharmacovigilance based on available endTB Project data for bedaquiline5
Vitamin D deficiency predicts latent TB reactivation independent of preventive therapy: a longitudinal study5
Continuity of TB services during the COVID-19 pandemic in China5
Measuring TB drug levels in the hair in adults and children to monitor drug exposure and outcomes5
A randomised controlled trial to evaluate a medication monitoring system for TB treatment5
Cost of TB services in the public and private sectors in Georgia (No 2)5
Diagnostic yield of sputum induction in patients with pleural tuberculosis at a tertiary care hospital in Karachi5
Complications of tuberculous meningitis and their effect on outcome in a tertiary care cohort5
The 100th anniversary of bacille Calmette-Guérin (BCG) and the latest vaccines against COVID-195
QT prolongation in the STREAM Stage 1 Trial5
TB preventive treatment in high- and intermediate-incidence countries: research needs for scale-up5
Bacille Calmette-Guérin (BCG) vaccine and the COVID-19 pandemic: responsible stewardship is needed5
COVID-19: ensuring continuity of TB services in the private sector5
Face masks – a sustainable measure to mitigate COVID-195
Concern over a COVID-19-related BCG shortage5
Opportunities to prevent and manage undernutrition to amplify efforts to end TB5
Effect of bronchial artery embolisation on the management of tuberculosis-related haemoptysis5
The diagnosis of lung cancer in the era of interventional pulmonology5
Key changes in the public health response to TB and HIV in South Africa5
Preventive treatment of drug-resistant TB in a rural setting4
How Big Tobacco uses disruptive tactics to deny child rights to be tobacco-free4
Density of cigarette retailers around educational facilities in Indonesia4
Completion of treatment for latent TB infection in a low prevalence setting4
Willingness to accept reimbursement for visits to an HIV clinic for tuberculosis preventive therapy4
Seasonal drivers of tuberculosis: evidence from over 100 years of notifications in Cape Town4
Chronic kidney disease, tuberculosis and climate change4
COVID-19 in Africa: community and digital technologies for tuberculosis management4
Density of tobacco advertising around schools4
Transforming essential services for tuberculosis during the COVID-19 pandemic: lessons from New York City4
The Asthma Drug Facility and the future management of asthma4
Time for a change: considering regimen changes in analyses of observational drug-resistant TB treatment cohort data4
In Reply: How TB and COVID-19 compare: an opportunity to integrate both control programmes4
TB in older people in Asia: why it is important4
A positive COVID-19 test is associated with high mortality in RR-TB-HIV patients4
Clinical standards for drug-susceptible pulmonary TB4
Depression, stigma and quality of life in people with drug-susceptible TB and drug-resistant TB in Vietnam4
Impact of influenza A co-infection with COVID-194
Epidemiology, pathogenesis, clinical presentation and management of TB in patients with HIV and diabetes4
How mechanistic in silico modelling can improve our understanding of TB disease and treatment4
Effect of malnutrition on the pharmacokinetics of anti-TB drugs in Ghanaian children4
Using a mobile application to improve pediatric presumptive TB identification in western Kenya4
Childhood TB in China: notification, characteristics and risk factors for outcomes, 2010–20174
Is effective patient support missing in the global response to multidrug-resistant tuberculosis?4
Tobacco use and quitting behaviour during COVID-19 lockdown4
Tuberculosis and diabetes mellitus: a dose-response relationship between the odds of tuberculosis and HbA1c4
COVID-19 and TB: a progression-regression conundrum4
A public health approach to increase treatment of latent TB among household contacts in Brazil4
Knowledge, attitudes and practices on childhood TB among healthcare workers4
Contribution of Xpert MTB/RIF to clinical diagnosis in adolescents with tuberculosis in Rio de Janeiro, Brazil4
Association between chronic airflow obstruction and socio-economic position in Morocco: BOLD results4
UNITE4TB: a new consortium for clinical drug and regimen development for TB4
A comparative analysis of asthma treatment guidelines and Essential Medicine Lists in sub-Saharan Africa4
Seasonality, climate change and tuberculosis: new data and old lessons4
The war in Ukraine and potential consequences for the TB epidemic in Europe4
The Bedaquiline Donation Program: progress and lessons learned after 4 years of implementation4
Disseminated Mycobacterium avium complex infection as a differential diagnosis of tuberculosis in HIV patients4
Therapeutic strategies and outcomes of MDR and pre-XDR-TB in Italy: a nationwide study4
Quantification of neutrophil and monocyte CD64 expression: a predictive biomarker for active tuberculosis4
COVID-19 and TB control in immigrant communities4
VIDAS® TB-IGRA reagents induce a CD4+ and CD8+ T-cell IFN-γ response for both TB infection and active TB4
The impact of COVID-19 on the TB response: data from the field4
Effects of comorbidities on quality of life in Filipino people with tuberculosis4
Helping Africa to breathe when COVID-19 strikes4
Adipokines and the risk of active TB: a nested case-control study4
Treatment outcomes in multidrug-resistant tuberculosis according to pyrazinamide susceptibility4
Decreased notification of TB cases during the COVID-19 pandemic4
Systematic rifampicin resistance errors with Xpert® MTB/RIF Ultra: implications for regulation of genotypic assays4
Incremental yield of Xpert® MTB/RIF Ultra over Xpert® MTB/RIF in the diagnosis of extrapulmonary TB3
Diagnostic yield of active case finding for tuberculosis at human immunodeficiency virus testing in Haiti3
Changes to TB care in an outpatient centre during the COVID‐19 pandemic3
TB outcomes and mortality risk factors in adult migrants at the Thailand-Myanmar border3
How COVID-19 can instruct TB research: ensuring the safety of researchers exposed to infectious disease3
Associations between air pollutants and peak expiratory flow and fractional exhaled nitric oxide in students3
Planning for TB elimination in Lebanon3
Epidemiology of tuberculosis among healthcare personnel in New York City3
Distinctive patterns of pulmonary function change according to baseline lung volume and diffusing capacity3
Implementing 3HP vs. IPT as TB preventive treatment in Pakistan3
Epidemiology and risk factors for extrapulmonary tuberculosis in Lebanon3
Treatment success, but living with the consequences of post-tuberculosis sequelae3
Using a geographic information system as a management tool for tuberculosis control3
Diagnostic code agreement for electronic health records and claims data for tuberculosis3
Leveraging differentiated HIV service delivery to expand tuberculosis preventive treatment: a call to action3
WHO target product profiles for TB preventive treatment3
Impact of mental disorders on active TB treatment outcomes: a systematic review and meta-analysis3
Screening for active and latent TB among migrants in France3
Subclinical tuberculosis and adverse infant outcomes in pregnant women with HIV3
Symptom and digital chest X-ray TB screening in South African prisons: yield and cost-effectiveness3
Effect of Global Fund financial support for patients with multidrug-resistant tuberculosis3
Isoniazid and verapamil modulatory activity and efflux pump gene expression in Mycobacterium tuberculosis3
Tuberculosis surveillance in adolescents: what to learn from European Union/European Economic Area data?3
Patterns of suboptimal adherence among adolescents treated for tuberculosis3
Presentation and outcome of patients with intracranial tuberculoma in a high HIV prevalence setting3
What to look for when using SUBsET for subnational TB incidence estimates3
TB in children and adolescents3
Fluorescein diacetate and rapid molecular testing for the early identification of rifampicin resistance in Mali3
How much does TB screening cost? A systematic review of economic evaluations3
Epidemiology and clinical characteristics of childhood TB identified using active and passive case finding3
National survey on the impact of the war in Ukraine on TB diagnostics and treatment services in 20223
Treatment outcomes and safety in children with rifampicin-resistant TB3
Work-related interstitial lung disease: what is the true burden?3
Impact of lung function on treatment outcome in patients with TB3
Clinical outcomes among patients with tuberculous meningitis receiving intensified treatment regimens3
Factors associated with tuberculosis-associated haemophagocytic syndrome: a multicentre case-control study3
Psychological distress among TB patients in sub-Saharan Africa3
Reasons why patients with tuberculosis in South Korea stop anti-TB treatment: a cross-sectional study3
Adapting a TB contact investigation strategy for COVID-193
Increase in disseminated TB during the COVID‐19 pandemic3
Pharmacokinetics of high-dose isoniazid in children affected by multidrug-resistant TB3
Introduction of bedaquiline for the treatment of drug-resistant TB in the Philippines3
Risk factors for the delayed diagnosis of extrapulmonary TB3
Prevalence and risk factors of tuberculosis disease in South African correctional facilities in 20153
Effect of 6-month vs. 8-month regimen on retreatment success for pulmonary TB3
Introducing new and repurposed TB drugs: the endTB experience3
Post-TB bronchiectasis: from pathogenesis to rehabilitation3
Acquired bedaquiline resistance in Karakalpakstan, Uzbekistan3
Country differences and determinants of yield in programmatic migrant TB screening in four European countries3
An assessment of current tuberculosis patient care and support policies in high-burden countries3
Global Asthma Report 2022: a wake-up call to enhance care and treatment for asthma globally3
Impact of COVID-19 on TB services in Korea3
Strengthened capacity of India´s bedaquiline Conditional Access Programme for introducing new drugs and regimens3
Engaging private pharmacies to help end TB in India3
Ethambutol-induced optic neuropathy in nontuberculous mycobacterial disease3
TB testing in HIV-positive patients prior to antiretroviral treatment3
Reference values of impulse oscillometry (IOS) for healthy Indian adults3
Impact of the COVID-19 pandemic on TB infection testing3
Determinants of treatment outcomes in patients with multidrug-resistant TB3
Prevalence of and risk factors for depressive symptoms in non-tuberculous mycobacterial pulmonary disease3
Undernutrition can no longer be an afterthought for global efforts to eliminate TB3
Community-based TB testing as an essential part of TB recovery plans in the COVID-19 era3
The impact of smoking on TB treatment outcomes includes recurrent TB2
Population pharmacokinetics of bedaquiline in patients with drug-resistant TB2
Air conditioners, airborne infection prevention and air pollution in buildings in New Delhi2
Clinical effects of TB sequelae in patients with COPD2
Diabetes mellitus is not a predictor of poor TB treatment outcomes2
COVID-19 effect on TB presentation and outcome2
Cost of TB services: approach and summary findings of a multi-country study (Value TB)2
Cost of TB prevention and treatment in the Philippines in 20172
Budget impact of next-generation sequencing for diagnosis of TB drug resistance in Moldova2
Early mortality during rifampicin-resistant TB treatment2
eHealth in TB clinical management2
Can isoniazid preventive therapy be scaled up rapidly? Lessons learned in Kenya, 2014–20182
Post-TB lung disease in three African countries2
Canadian immigrants´ awareness and perceptions of TB infection and TB2
TB case fatality and recurrence in a private sector cohort in Mumbai, India2
Latent tuberculosis in pregnant women: a patient perspective2
TB and COVID-19 coinfection2
Tuberculin skin test reaction depends on type of purified protein derivative: implications for cut-off values2
Assessment of knee extensor and flexor function using isokinetic test in COPD: impact on exercise capacity2
Prevention care cascade in people exposed to drug-resistant TB2
Costs along the TB diagnostic pathway in Uganda2
Length of hospital stay for TB varies with comorbidity and hospital location2
Progress on indoor air quality regulation in India2
Reporting of interferon-gamma release assay results close to cut-off values2
Active case‐finding in contacts of people with TB2
Post-TB disease: a new topic for investigation—and why it matters2
Evidence for supercoughers in an analysis of six tuberculosis cohorts from China, Peru, The Gambia and Uganda2
Disease progression in patients with COVID-19: a retrospective cohort study in China2
Infection status of contacts is not associated with severity of TB in the index case2
Discovering a new drug is only the beginning: progress and challenges in expanding access to BDQ for MDR-TB treatment2
A self-rated health score predicts severe disease and high mortality in patients with pulmonary TB2
Development and validation of novel diagnostic nomogram for tuberculous pleurisy based on TB-IGRA results2
Disseminated TB in inpatient deaths at a tertiary care centre: an autopsy study over three decades2
Post-TB outcome science: a sub-discipline for TB survivorship studies?2
Plasma pharmacokinetics of bedaquiline administered by nasogastric tube in an intensive care unit2
Whole-genome sequencing differentiates relapse from re-infection in TB2
Avoiding pitfalls in calculating the population attributable fraction of undernutrition for TB2
Decline in TB incidence during the COVID-19 pandemic2
Therapeutic drug monitoring and TB treatment outcomes in patients with diabetes mellitus2
The Barts Health NHS Trust COVID-19 cohort: characteristics, outcomes and risk scoring of patients in East London2
Outdoor air pollution and respiratory health2
GPT-4, artificial intelligence and implications for publishing2
Shortening MDR-TB treatment: is treating more patients with fewer drugs better?2
Pediatric delamanid treatment for children with rifampicin-resistant TB2
Lack of essential medical resources leaves Africa breathless2
Post-COVID-19 tomographic abnormalities2
Call to action for an invigorated drive to scale up TB prevention2
Expanding the use of dolutegravir-based antiretroviral therapy in multidrug-resistant TB2
Introduction of the Simple One-Step stool Xpert Ultra method to detect TB in children and adults2
Uncovering reasons for treatment initiation delays among children with TB in Lima, Peru2
Concomitant pulmonary disease is common among patients with extrapulmonary TB2
Successful treatment of patients severely ill with COVID-192
Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis in China2
COVID-19 vaccine-induced thrombosis2
Health-related quality of life of inpatients and outpatients with TB in rural Malawi2
High‐resolution CT in smoking‐related interstitial lung diseases2
Caregiver willingness to give TPT to children living with drug-resistant TB patients2
Efficacy and safety of video-assisted thoracoscopic surgery for pulmonary TB2
Interferon-gamma release assays for latent tuberculosis infection screening in Canadian federal correctional facilities2
Health-related quality of life among persons treated for tuberculosis in a European setting2
Rapid development of a novel portable negative pressure device2
Guidance is needed to mitigate the consequences of analytic errors during antimicrobial susceptibility testing for TB2
Sputum culture conversion definitions and analytic practices for multidrug-resistant TB2
Aspergillus fumigatus-specific antibodies in patients with chronic tuberculosis2
Impact of COVID-19 on diagnosis and testing for TB in a high-resource, low-burden setting2
Survey of practices in managing abdominal TB2
TB prevalence among patients with diabetes in Bangladesh2
TB in the elderly: clinical features and outcomes2
Adverse effects and duration of treatment of TB in Canterbury, New Zealand2
Prevalence of and risk factors for respiratory symptoms in an adult urban population2
TB reporting declines in priority countries during the COVID-19 pandemic2
Recent epidemiological trends in extrapulmonary TB in Galicia, Spain2
Efflux pump gene expression study using RNA-seq in multidrug-resistant TB2
Use of 3HP for TB preventive treatment in prisons2
Need for caution when interpreting Xpert® MTB/RIF results for rifampin resistance among children2
Concordance of three approaches for operationalizing outcome definitions for multidrug-resistant TB2
Multidrug-resistant tuberculosis in Lisbon: unfavourable treatment and associated factors, 2000–20142
TB‐related knowledge and stigma among pregnant women in low‐resource settings2
Introduction and scaling up of new drugs for drug-resistant TB: experiences from the Americas2
Introducing bedaquiline: experiences from the Challenge TB Project2
Impact of Rv0678 mutations on patients with drug-resistant TB treated with bedaquiline2
Parental TB associated with offspring asthma and rhinitis2
Finding gaps in routine TB surveillance activities in Bangladesh2
Understanding the global tuberculosis epidemic: moving towards routine whole-genome sequencing2
Airflow limitation as a risk factor for vascular stiffness2
Long-term mortality of patients with tuberculosis in Korea2
Having diabetes and being underweight in Asia: a potent risk factor for tuberculosis2
TB consilia and quality of tuberculosis management2
Financial impact of COVID-19 on TB patients in India2
Laboratory costs of diagnosing TB in a high multidrug-resistant TB setting2
Overcoming barriers to the access and uptake of newer drugs for multidrug-resistant TB2
Characteristics, risk factors and outcomes of critically ill patients with active TB2
Digital adherence technology for TB: focus on livelihoods as well as lives2
The household economic burden of drug-susceptible TB diagnosis and treatment in The Gambia1
The economic burden of TB-affected households in DR Congo1
Xpert Ultra in diagnosing extrapulmonary TB: accuracy and trace calls1
Use of a molecular bacterial load assay to distinguish between active TB and post-TB lung disease1
Down Syndrome and COVID-19: not always a poor prognosis1
Incidence of TB among kidney transplant recipients in a setting with universal isoniazid prophylaxis1
A roadmap for lifting restrictive measures for COVID-191
Idiopathic and post-infectious bronchiectasis: take care with the diagnosis!1
Aspergillus infection is an important complication of post-TB bronchiectasis1
Key messages and partnerships to raise awareness and improve outcomes for people with asthma and COPD in low- and middle-income countries1
Benefits of community-based TB screening vs. passive case finding1
Occupational safety and health for respiratory health: a comprehensive approach for an often-forgotten issue1
TB stigma and its correlates among HIV-positive people who inject drugs in Ukraine1
Outcomes of WHO-conforming, longer, all-oral multidrug-resistant TB regimens and analysis implications1
Reducing the burden of TB among migrants to low TB incidence countries1
An approach for improving the quality of country-level TB modelling1
Evaluation of point-of-care algorithms to detect diabetes during screening for latent TB infection1
High prevalence of pre-diabetes among people living with HIV in a high TB burden setting1
Diagnostic performance of whole-genome sequencing for identifying drug-resistant TB in Thailand1
Completeness of TB notification in Portugal, 2015: an inventory and capture-recapture study1
TB screening, prevention and treatment cascade in a Malawi prison1
Drug-resistant tuberculosis patient care journeys in South Africa: a pilot study using routine laboratory data1
Why TB programmes should assess for comorbidities, determinants and disability at the start and end of TB treatment1
Evidence and ethical considerations for the treatment of contacts exposed to drug-resistant TB1
Prevalence of COPD among women and relation with cooking fuel choice in Ouagadougou, Burkina Faso1
Feasibility and acceptability of asynchronous VOT among patients with MDR-TB1
Where next with for vitamin D and tuberculosis?1
A scoping review of interventions to mitigate common non-communicable diseases among people with TB1
Role of symptom and chest X-ray screening in evaluating child household contacts for pulmonary TB1
Referral of presumptive TB among operators of community medicine outlets1
TB and chronic pulmonary aspergillosis: a few relevant points1
Global availability of susceptibility testing for second-line anti-tuberculosis agents1
Hospitalizations with TB, California, 2009–20171
Pulmonary TB and chronic pulmonary aspergillosis1
The need for effective drugs for TB prevention: set your goals high, and don´t stop till you get there1
Updated guidelines for child and adolescent TB1
Failure or relapse predictors for the STREAM Stage 1 short regimen for RR-TB1
Tuberculosis surveillance and its discontents: the ethical paradox1
Culture-negative TB: clinical characteristics, risk factors and treatment outcomes1
Determinants of non-adherence to anti-TB treatment in high income, low TB incidence settings: a scoping review1
Tuberculosis in a Spanish cohort of children living with HIV: the CHOTIS study (Childhood HIV & TB study)1
Surgical treatment for non-tuberculous mycobacterial pulmonary disease: analysis of prognostic factors1
Influence of type of dwelling on the prevalence of chronic respiratory diseases in Ho Chi Minh City, Viet Nam1
Down syndrome and COVID-19, a combination with a poor prognosis1
The absence of evidence of cure is not a risk for recurrent TB among patients treated for TB1
Hope rises out of despair: bedaquiline and linezolid for the treatment of drug-resistant TB1
TB diagnosis and treatment during the COVID-19 pandemic1
One third of child TB cases were missing from the national TB register in Botswana1
The importance of pharmacokinetics/pharmacodynamics assessment in Phase IIB/III trials for MDR-TB treatment1
Travel reimbursements, distance to health facility and preventive treatment cascade for drug-resistant TB1
Isolation and purification of lipoarabinomannan from urine of adults with active TB1
Best practices for the care of pregnant people living with TB1
Beyond measurement: taking bold multisector actions towards zero catastrophic costs and suffering due to TB1
Stress, asthma and allergic sensitisation to house dust mite in children1
Bridging the gap: key evidence needed to strengthen global policies to end TB1
TB and COVID-19 in migrants – the need to focus on both conditions1
Time to care-seeking for TB symptoms1
Measuring anti-TB drug concentrations in hair: unlocking the door to cumulative drug exposure and treatment outcome1
Airways flow limitation in symptomatic adult cannabis smokers1
Nosocomial TB in two neonatal intensive care units at a tertiary care centre: infection risk and outcomes1
Multidrug-resistant tuberculosis care in the United States1
Over the limit: tuberculosis and excessive alcohol use1
Impact of COVID-19 on TB detection in the private sector in Nepal1
Assessment of TB treatment on patient well-being1
Geospatial analysis and factors associated with poor outcome for multidrug-resistant tuberculosis1
Trends in rifampicin and isoniazid resistance in patients with presumptive TB1
Finding the right balance between efficacy and tolerability for TB treatment: the search continues1
Financial support to the poor for the detection of smear-negative pulmonary and extra-pulmonary TB in Bangladesh1
Effectiveness of two tobacco cessation methods among TB patients1
TB and women: a call to action1
Computer-assisted interpretation of chest radiographs: signs of hope for silicosis and tuberculosis1
Why are people still dying of drug-susceptible TB in Paris in the 21st century?1
Uptake of the lateral flow urine LAM test in Europe and Central Asia1
Assessment of asthma control in users of oral anti-asthma medications1
Diagnosis patterns for rifampicin-resistant TB after onset of COVID-191
Clinical features, microbiology and lung function in post-TB bronchiectasis compared to other aetiologies1
Immune response against TB and non-tuberculous mycobacterial pulmonary disease1
Non-tuberculous mycobacteria in sputum cultures in Suriname1
Reflecting on the relationship between residential schools and TB in Canada1
One size does not fit all: reaching agricultural workers in South Africa with TB services1
Diagnosis of paediatric TB using Xpert® MTB/RIF Ultra on fresh respiratory samples1
Prevalence and risk factors of airflow obstruction in a Caribbean population1
Targeted TB control in migrants to low-burden countries1
Demographic and socio-economic risk factors associated with self-reported TB1
ScreenTB: a tool for prioritising risk groups and selecting algorithms for screening for active tuberculosis1
Improving enrolment for TB preventive treatment1
Evaluation of QFT-Plus performance using blood samples stored at room temperature1
User perspectives on the use of X-rays and computer-aided detection for TB1
Impact of the bacillary load on the accuracy of rifampicin resistance results by Xpert® MTB/RIF1
The importance of knowing why TB patients stop anti-TB treatment1
Improving outcomes for multidrug-resistant TB treatment1
Use of interactive messaging to reduce pre-diagnosis loss to follow-up for TB care1
Effectiveness of a community-based intervention to prevent childhood TB in Lesotho1
Effectiveness of GenoType MTBDRsl in excluding TB drug resistance in a clinical trial1
The environment is a first order issue for lung health1
The acquisition of Mycobacterium tuberculosis infection in village doctors in China: a prospective study1
Indoor pet allergen exposures modify the effects of chemical air pollutants on respiratory symptoms1
Flupentixol/melitracen for chronic refractory cough after treatment failure with other neuromodulators1
Strategic approach to optimisation of TB contact investigation in Nigeria1
Advancing TB research using digitized programmatic data1
What will it take to achieve meaningful action on tuberculosis among Indigenous Peoples?1
The economic burden of TB faced by patients and affected families in Papua New Guinea1
Treatment outcomes and safety of bedaquiline, delamanid, and linezolid in multidrug-resistant TB1
War in Ukraine and the TB epidemic1
Recent developments in the diagnosis and treatment of extrapulmonary non-tuberculous mycobacterial diseases1
From Peruvian mummies to living humans: first case of pulmonary tuberculosis caused by Mycobacterium pinnipedii1
Potential drug–drug interactions among hospitalised TB patients1
Use of chest radiography screening for TB: a re-evaluation of the Kolín study1
Dactylitis due to accidental needle-stick injury with a BCG-loaded syringe1